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AIM To describe fatigue in Duchenne muscular dystrophy (DMD) from patients’ and parents’
perspectives and to explore risk factors for fatigue in children and adolescents with DMD.
METHOD A multicentre, cross-sectional study design was used. Seventy-one patients (all
males; median age 12y, age range 5–17y) identified via the Canadian Neuromuscular Disease
Registry, and their parents completed questionnaires. Subjective fatigue was assessed using
the Pediatric Quality of Life Inventory Multidimensional Fatigue Scale by child self-report and
parent proxy-report.
RESULTS Patients with DMD across ages and disease stages experienced greater fatigue
compared to typically developing controls from published data. Sleep disturbance symptoms
were associated with greater fatigue by child self-report (q=–0.42; p=0.003) and parent proxyreport (q=–0.51; p<0.001). Depressive symptoms were associated with greater fatigue by child
self-report (q=–0.46; p<0.001) and parent proxy-report (q=–0.45; p<0.001). Lower functional ability
was associated with greater fatigue by parent proxy-report (q=0.26; p=0.03). Physical activity
level, and musculoskeletal, respiratory, and cardiac function were not associated with fatigue.
INTERPRETATION In paediatric DMD, sleep disturbance symptoms and depressive symptoms
are potentially modifiable factors associated with fatigue, warranting additional investigation
to facilitate the development of therapeutic strategies to reduce fatigue.

Duchenne muscular dystrophy (DMD) is an X-linked
recessive disease characterized by the absence of, or defect
in, the sarcolemma protein dystrophin, resulting in progressive muscle degeneration and loss of ambulation.
Additional musculoskeletal, respiratory, and cardiac complications emerge as DMD advances.1 Children and adolescents with DMD are at increased risk of developmental,
emotional, and behavioural problems.2 Improved management with corticosteroid therapy and non-invasive ventilation (NIV) has prolonged survival. There is no cure for
DMD; therapeutic strategies aim to delay disease progression and improve quality of life.1 Fatigue recently emerged
as the strongest predictor of poor health-related quality of
life in children and adolescents with DMD, from both
patients’ and caregivers’ perspectives.3
Subjective fatigue, the focus of this study, is defined as a
lack of energy or the existence of weakness or exhaustion —
mentally, physically, or both.4 Subjective fatigue differs
from physiological fatigue or fatigability, which refer to
difficulty maintaining physical or mental activity at a
desired level.5 In neuromuscular disorders, physiological
fatigue is related to functioning of the central or peripheral
nervous system (lower motor neuron, neuromuscular junction, or muscle), and assessed objectively in a laboratory
setting.5 Subjective fatigue is ideally assessed using
© 2019 Mac Keith Press

validated standardized questionnaires addressing the
patient perspective.
Fatigue is frequent and among the most disabling symptoms in adult neuromuscular disorders, but it is not well
characterized in paediatric neuromuscular disorders,
including DMD. Fatigue may limit children’s participation
in age-related recreational and school activities, and consequently delay development, which is already problematic in
children and adolescents with DMD. This may, in turn,
ultimately impact social, educational, and occupational
pursuits during adulthood.6
Data on mechanisms, prevention, and management of
fatigue in neuromuscular disorders and paediatric chronic
health conditions are limited, with most studies of the latter population focusing on childhood cancer.7,8 To our
knowledge, no study has explored factors associated with
fatigue in DMD. Therefore, identifying fatigue and understanding its determinants may facilitate the development of
therapeutic strategies to reduce fatigue and improve
health-related quality of life.
To facilitate best clinical practice for the prevention and
management of fatigue in children and adolescents with
DMD, an understanding of patients’ and parents’ perspectives of fatigue is needed. Parents’ perceptions of their
child’s health influences healthcare utilization — particularly
DOI: 10.1111/dmcn.14248

245

when the child is too young, too cognitively impaired, or too
ill to self-manage his or her own health.9 This study aimed
to describe fatigue in DMD from patients’ and parents’
perspectives, and to explore associations of patient characteristics with child/adolescent self-reported and parent
proxy-reported fatigue.

METHOD
A multicentre cross-sectional study design was used. Eligible patients were identified via the Canadian Neuromuscular Disease Registry (CNDR), a clinic-based registry that
includes patients from nine paediatric neuromuscular clinics across Canada.10 Data were collected using mailed
paper questionnaires and registry data collected at patients’
routine clinic visits. Eligible patients and their primary
caregivers were sent questionnaires between July 2016 and
November 2016. Patients and parents were instructed to
complete their respective questionnaires independently. If
a patient was unable to complete their questionnaire independently, the parent was instructed to read the questions
to the patient verbatim without providing interpretation,
and to indicate the patient’s answers on the questionnaire
without providing guidance on how to respond. Parents of
young children were instructed to act as interviewers for
their child. A four-contact mailing strategy was used to
maximize the response rate in accordance with the Tailored Design Method.11 Patient clinical characteristics
were retrieved from the CNDR database. Implied consent
was assumed for patients and parents who returned completed questionnaires.
Approval for the study was obtained from the Research
Ethics Board at Western University and the CNDR.
Participants
Eligible patients were identified according to the following
inclusion criteria: (1) patients have consented, or a parent
or guardian has consented on their behalf, to be notified
by the CNDR of research opportunities; (2) patients with
a DMD diagnosis confirmed by genetic testing or muscle
biopsy, and clinical presentation consistent with DMD; (3)
patients are males; (4) patients are between 5 and 17 years
of age; and (5) patients have a primary caregiver available
to complete a parent questionnaire. Patients were ineligible
according to the following exclusion criteria: (1) both
patient and parent were unable to complete questionnaires,
even with assistance, due to limited literacy, a communication disorder, or cognitive impairment; and (2) patient has
a comorbidity unrelated to DMD, which may influence
study outcomes.
Measures
Age, musculoskeletal characteristics (ambulatory status,
wheelchair use, scoliosis status, corticosteroid therapy status), respiratory characteristics (forced vital capacity, ventilatory status), and cardiac characteristics (left ventricular
ejection fraction) were retrieved from the CNDR database.
Fatigue, physical activity level, functional ability related to
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What this paper adds
Fatigue is a major issue in paediatric Duchenne muscular dystrophy (DMD)
across ages and disease stages.
Sleep disturbance and depressive symptoms are significantly associated with
fatigue in paediatric DMD.

activities of daily living, depressive symptoms, and sleep disturbance symptoms were assessed using survey measures.
Fatigue was measured using the Pediatric Quality of Life
Inventory (PedsQL) Multidimensional Fatigue Scale (MFS)
by child self-report and parent proxy-report. Parent proxyreport forms are parallel to child self-report forms and
assess parents’ perceptions of their child’s fatigue. The
PedsQL MFS is composed of three domains: General Fatigue (six items, e.g. ‘I feel tired’; ‘I feel too tired to do
things that I like to do’), Sleep/Rest Fatigue (six items, e.g.
‘I feel tired when I wake up in the morning’), and Cognitive Fatigue (six items; e.g. ‘It is hard for me to keep my
attention on things’; ‘It is hard for me to think quickly’).
Respondents were asked to indicate how much of a problem each item had been in the past month. A total score
and domain scores were computed, each ranging from 0 to
100, with higher scores indicating less fatigue due to
reverse scoring. Total scores were computed if 50% or
more items were completed. Domain scores were computed if 50% or more items were completed within each
domain.9 PedsQL MFS scores of our sample were compared with scores of typically developing children derived
from a previous study.12 Data exclusively on typically
developing males aged 5 to 17 years were provided by the
developers of the PedsQL MFS and authors of the previously published study12 for our comparison.
Physical activity level was assessed by child self-report
using an adapted Physical Activity Questionnaire for Children and Adolescents (PAQ-C/A). The PAQ-C/A was
adapted such that all items were applicable to ambulant
and non-ambulant patients with DMD. Respondents were
instructed to consider any activity that causes them to
sweat, breathe hard, or causes their legs or arms to feel
tired. The PAQ-C/A measures physical activity level during the past 7 days. PAQ-C/A scores range from 1 (low
physical activity) to 5 (high physical activity).13 In the case
of missing items, a score was not computed.
Functional ability related to activities of daily living was
assessed by parent proxy-report using the DMD Functional Ability Self-Assessment Tool, which assesses physical
and respiratory functioning at all disease stages in patients
with DMD. Respondents were asked to rate their current
level of functioning in relation to common activities of
daily living, upper and lower extremities, and ventilation
status. DMD Functional Ability Self-Assessment Tool
scores range from 0 (low functional ability) to 23 (high
functional ability).14 In the case of missing items, a total
score was computed by dividing the sum of completed
items by the maximum possible score of completed items,
and multiplying this fraction by the maximum possible
score of all items.

Depressive symptoms were assessed by child self-report
using the Center for Epidemiological Studies Depression
Scale for Children. Respondents were asked to indicate how
strongly they experienced certain feelings during the past
week. The Center for Epidemiological Studies Depression
Scale for Children scores range from 0 to 60, with higher
scores indicating more depressive symptoms.15 In the case of
missing items, a total score was computed after imputing the
mean of completed items as the response for missing items.
Sleep disturbance symptoms were assessed by parent
proxy-report using the Sleep Disturbance Scale for Children, which is composed of six domains: disorders of initiating and maintaining sleep, sleep-related breathing
disorders, disorders of arousal, sleep–wake transition disorders, disorders of excessive somnolence, and sleep hyperhidrosis. Respondents were asked to consider their child’s
sleep behaviour during the past 6 months. A total score
and domain scores were computed. Possible Sleep Disturbance Scale for Children total scores range from 26 to
130, with higher scores indicating more sleep disturbance
symptoms.16 In the case of missing items, the total and
domain scores were not computed.

Statistical analysis
For patient characteristics, median and interquartile range
(IQR) were computed for continuous variables, and frequencies and percentages were computed for categorical
variables. Mean and standard deviations (SD) or median
and IQR were computed for child self-report and parent
proxy-report PedsQL MFS scores. Associations between
child self-reports and parent proxy-reports of PedsQL
MFS scores were examined using pairwise correlation analyses with Spearman’s rank correlation coefficient.
Bivariate analyses were conducted to explore associations
of patient characteristics with child self-reported and parent proxy-reported fatigue. Associations of continuous variables with PedsQL MFS scores were examined using
pairwise correlation analyses with Spearman’s rank correlation coefficient. For dichotomous variables, unpaired twosample t-tests or Mann–Whitney U test were used to assess
differences in PedsQL MFS scores between categories. For
categorical variables of more than two categories, one-way
analysis of variance (ANOVA) or Kruskal–Wallis tests were
used to assess differences in PedsQL MFS scores between
categories. Bivariate analyses were performed using pairwise deletion. Exploratory multivariable linear regression
analyses were used to explore the adjusted associations of
patient characteristics with child self-reported and parent
proxy-reported fatigue. Multivariable analyses were performed using complete case analysis (listwise deletion).
Statistical analyses were performed using Stata version
13.0 (StataCorp LP, College Station, TX, USA). A twosided level of significance at p=0.05 was assumed.
RESULTS
Of 193 eligible participants identified and sent questionnaires, 71 patient-parent pairs returned completed

questionnaires. Both patient and parent questionnaires
were completed by 64 patient–parent pairs, while for five
participants only the parent questionnaire was completed
and for two participants only the patient questionnaire was
completed. Patient clinical characteristics for participants
and non-participants are summarized in Table I. Participating and non-participating patients were similar with
respect to age and musculoskeletal, respiratory, and cardiac
characteristics, including scoliosis and invasive ventilation
(data not presented). The ratio of ambulant to non-ambulant patients was lower for participating patients compared
to non-participating patients.
Descriptive statistics for PedsQL MFS scores are presented in Table II, along with PedsQL MFS scores of typically developing males for comparison.12 Males with
DMD experienced greater fatigue (lower scores) compared
with typically developing peers from published data across
domains, by child self-report and parent proxy-report.12
Mean (SD) age of typically developing males was 12 years
11 months (3y 2mo) and ranged from 5 to 17 years.
PedsQL MFS scores by child self-report were significantly
associated with PedsQL MFS scores by parent proxyreport: total fatigue (q=0.69; p<0.001), general fatigue
(q=0.63; p<0.001), sleep/rest fatigue (q=0.50; p<0.001), and
cognitive fatigue (q=0.68; p<0.001).
Correlation analysis between continuous variables and
PedsQL MFS scores by child self-report and parent
proxy-report are presented in Tables III and IV respectively. Scatter plots of total fatigue versus physical activity
level, functional ability, depressive symptoms, and sleep
disturbance symptoms can be seen in Figures S1 to S8

Table I: Comparison of clinical characteristics retrieved from the
Canadian Neuromuscular Disease Registry between participating and
non-participating patients
Participating
patients (n=71)
Age, y
12 (9–15)
Musculoskeletal characteristics
Unsupported ambulation
Ambulant
42 (59)
Non-ambulant
28 (39)
Wheelchair use
Never
30 (42)
Intermittent
16 (23)
Permanent
17 (24)
Corticosteroid therapy
Never
9 (13)
Past
1 (1)
Current
52 (73)
Respiratory characteristics
Forced vital capacity
88 (72–99)
Non-invasive ventilatory support
No
66 (93)
Part-time
2 (3)
Full-time
2 (3)
Cardiac characteristics
Left ventricular ejection
64 (60–67.2)
fraction

Non-participating
patients (n=122)
12 (10–14)

84 (69)
31 (25)
47 (39)
38 (31)
27 (22)
8 (7)
2 (2)
101 (83)
82.5 (67–94.5)
105 (86)
6 (5)
–
63.9 (59.5–68.5)

Data are frequency (%) or median (IQR).
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Table II: Descriptive statistics for the Pediatric Quality of Life
Inventory Multidimensional Fatigue Scale by child self-report and parent
proxy-report
DMD sample
n
Child self-report
Total
66
fatigue
General
66
fatigue
Sleep/rest
66
fatigue
Cognitive
65
fatigue
Parent proxy-report
Total
69
fatigue
General
69
fatigue
Sleep/rest
69
fatigue
Cognitive
69
fatigue

Typically developing sample12

Median (IQR)

Mean (SD)

n

Mean (SD)

69.4 (62.5–81.9)

71.6 (15.2)

110

82.6 (13.2)

70.8 (58.3–83.3)

70.2 (19.7)

87.5 (14.4)

75.0 (64.6–87.5)

74.0 (17.5)

76.9 (17.9)

70.8 (54.2–91.7)

70.9 (23.0)

83.4 (15.8)

69.4 (58.3–84.7)

70.8 (16.0)

62.5 (45.8–79.2)

64.2 (20.1)

88.8 (13.6)

79.2 (66.7–91.7)

76.9 (18.0)

87.8 (14.5)

75.0 (54.2–91.7)

69.7 (24.6)

88.1 (15.3)

121

88.3 (11.6)

DMD, Duchenne muscular dystrophy.

(online supporting information). Greater physical activity
level was significantly associated with greater general fatigue by child self-report. Lower functional ability was significantly associated with greater general fatigue by child
self-report, and with greater total fatigue, general fatigue,
and sleep/rest fatigue by parent proxy-report. More depressive symptoms were significantly associated with greater
total fatigue, general fatigue, sleep/rest fatigue, and cognitive fatigue by child self-report and parent proxy-report.
More total sleep disturbance symptoms were significantly
associated with greater total fatigue, general fatigue, sleep/
rest fatigue, and cognitive fatigue by child self-report and
parent proxy-report. Significant correlations with fatigue
were most frequently observed for disorders of initiating
and maintaining sleep, disorders of arousal, sleep/wake
transition disorders, and disorders of excessive somnolence
(Tables SI and SII, online supporting information).

Parent proxy-reported sleep/rest fatigue was greater for
patients treated with part-time NIV compared with patients
not treated with NIV, as demonstrated by Kruskal–Wallis
test (v2=7.02; df=2; p=0.03), followed by post hoc analysis
using Dunn’s test (p=0.03).17 NIV status was not associated
with other domains of fatigue (data not presented). Musculoskeletal characteristics (ambulatory status, wheelchair use,
scoliosis status, corticosteroid therapy status) were not associated with fatigue (data not presented).
Because bivariate analyses did not consistently demonstrate significant associations between objective measures
of musculoskeletal, respiratory, and cardiac function and
fatigue, overall functional ability may be more related to
fatigue than any single musculoskeletal, respiratory, or cardiac characteristic. Thus, functional ability measured using
the DMD Functional Ability Self-Assessment Tool was
included as a covariate in the multivariable linear regression analyses, rather than single measures of musculoskeletal, respiratory, and cardiac function.
Multivariable analyses (n=41) demonstrated that physical
activity level, functional ability, depressive symptoms, and
sleep disturbance symptoms explained 38% of the variability in child self-reported total fatigue and 44% of the variability in parent proxy-reported total fatigue. Physical
activity level was not associated with total fatigue by
child self-report (b=2.50; p=0.37) or parent proxy-report
(b=–1.37; p=0.61), while adjusting for functional ability,
depressive symptoms, and sleep disturbance symptoms.
Functional ability was significantly associated with greater
total fatigue by parent proxy-report (b=0.68; p=0.03), but
not child self-report (b=–0.18; p=0.57), while adjusting for
physical activity level, depressive symptoms, and sleep disturbance symptoms. Depressive symptoms were not associated with total fatigue by child self-report (b=–0.32;
p=0.31) or parent proxy-report (b=–0.28; p=0.36), while
adjusting for physical activity level, functional ability, and
sleep disturbance symptoms. More sleep disturbance symptoms were significantly associated with greater total fatigue
by child self-report (b=–0.84; p=0.001) and parent proxyreport (b=–0.91; p<0.001), while adjusting for physical
activity level, functional ability, and depressive symptoms.

Table III: Correlation analyses between child characteristics and Pediatric Quality of Life Inventory Multidimensional Fatigue Scale scores by child
self-report, using Spearman's rank correlation coefficient (q)
Total fatigue
Clinical characteristics
Age, y
Forced vital capacity
Left ventricular ejection fraction
Child self-report or parent proxy-report measures
Physical Activity Questionnaire for Children and Adolescents
Duchenne Muscular Dystrophy Functional Ability Self-Assessment Tool
Center for Epidemiological Studies Depression Scale for Children
Sleep Disturbance Scale for Children
Data are q (n). ap<0.05; bp<0.001.
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0.01 (66)
0.29 (40)
0.00 (42)
0.13
0.05
–0.46b
–0.42a

(58)
(64)
(66)
(46)

General
fatigue
–0.19 (65)
0.34a (39)
0.10 (41)
0.27a
0.30a
–0.30a
–0.32a

(57)
(63)
(65)
(45)

Sleep/rest
fatigue
–0.06 (66)
0.15 (40)
–0.22 (42)
0.12
-0.01
-0.30a
–0.30a

(58)
(64)
(66)
(46)

Cognitive
fatigue

0.23 (66)
0.03 (40)
0.08 (42)
–0.06
–0.13
–0.46b
–0.33a

(58)
(64)
(66)
(46)

Table IV: Correlation analyses between child characteristics and Pediatric Quality of Life Inventory Multidimensional Fatigue Scale scores by parent
proxy-report, using Spearman's rank correlation coefficient (q)
Total
fatigue
Clinical characteristics
Age, y
Forced vital capacity (%)
Left ventricular ejection fraction (%)
Child self-report or parent proxy-report measures
Physical Activity Questionnaire for Children and Adolescents
Duchenne Muscular Dystrophy Functional Ability Self-Assessment Tool
Center for Epidemiological Studies Depression Scale for Children
Sleep Disturbance Scale for Children

0.06 (69)
0.12 (40)
0.06 (41)
0.09
0.26a
–0.45b
–0.51b

(57)
(69)
(64)
(50)

General
fatigue
–0.10 (69)
0.22 (40)
0.22 (41)
0.16
0.30a
–0.37a
–0.45a

(57)
(69)
(64)
(50)

Sleep/rest
fatigue
–0.18 (69)
0.07 (40)
–0.07 (41)
0.18
0.3a
–0.35a
–0.48a

(57)
(69)
(64)
(50)

Cognitive
fatigue

0.20 (69)
–0.01 (40)
0.02 (41)
–0.11
0.08
–0.32a
–0.34a

(57)
(69)
(64)
(50)

Data are q (n). ap<0.05; bp<0.001.

DISCUSSION
To our knowledge, this is the first study to describe fatigue
and to identify factors associated with fatigue in paediatric
DMD across the full spectrum of ages and disease stages
from patients’ and parents’ perspectives. Fatigue is a
prominent concern in children and adolescents with DMD,
highlighting the need for fatigue to be addressed in routine
care of affected males. Males with DMD experienced
greater fatigue than typically developing males in a previous study,12 from both patients’ and parents’ perspectives.
Child self-reported and parent proxy-reported fatigue
scores of males with DMD in our study were comparable
to previously published scores of a multicentre cohort of
ambulant males with DMD18, as well as scores of children
and adolescents with cancer, for whom fatigue is recognized as a frequent and debilitating symptom.19
Of the patient characteristics explored in our study, sleep
disturbance symptoms and depressive symptoms emerged
as the strongest correlates of fatigue. Lower functional
ability was associated with greater fatigue from parents’
perspective only. Thus, parents may be more likely to perceive their child’s fatigue as an outcome of, or contributor
to, the progressive functional decline associated with
DMD than patients themselves. Physical activity level and
clinical characteristics including age and musculoskeletal,
respiratory, and cardiac function were not consistently
associated with fatigue. These findings should be interpreted with caution, considering that fatigue may not
manifest as a symptom of musculoskeletal and cardiorespiratory decline until the late ambulatory to non-ambulatory
stages, or in adulthood. Patients in our sample had relatively preserved cardiorespiratory function.
Because sleep disturbances are frequent in paediatric
DMD, and variations exist in their assessment and management in clinical practice, sleep disturbance symptoms may
be a modifiable factor associated with fatigue.20,21 More
sleep disturbance symptoms were associated with greater
fatigue from both patients’ and parents’ perspectives. Sleeprelated breathing disorders, of non-obstructive and obstructive origin, are common in DMD.20 In our study, symptoms
of sleep-related breathing disorders did not emerge as a
correlate of fatigue. However, the accuracy of parent

proxy-reported symptoms of sleep-related breathing disorders compared with objective sleep measurements is
unclear.20 Moreover, symptoms such as restless sleep, nightmares, morning confusion, and excessive daytime sleepiness
may be related to sleep-related breathing disorders, but were
scored as items of other domains in the Sleep Disturbance
Scale for Children.16 Thus, the lack of association between
sleep disordered breathing and fatigue should be interpreted
cautiously. Symptoms of disorders of initiating and maintaining sleep, disorders of arousal, sleep-wake transition disorders, and disorders of excessive somnolence demonstrated
the strongest associations with fatigue. Disorders of initiating and maintaining sleep and disorders of excessive somnolence are prevalent in an estimated 30% and 11% of males
with DMD respectively.20 Thus, clinical sleep evaluations in
males with DMD should not be limited to detecting sleeprelated breathing disorders.
Sleep evaluations in patients with DMD are recommended as early as the ambulatory stage, or at the onset of
daytime symptoms of sleep disordered breathing or abnormal pulmonary function tests.22 Because overnight pulse
oximetry with capnography has limited utility for detecting
sleep disturbances not associated with hypoxemia or hypercapnia, and because there is a poor correlation between
daytime symptoms, abnormal pulmonary function, and
sleep disturbances, a ‘polysomnography for all policy’ has
been proposed.23 Polysomnography is important for indicating the need for timely intervention with NIV, which
can reduce symptoms of sleep disordered breathing and
potentially confer a beneficial effect on fatigue.
Sleep can be further complicated by disease-related, psychological, and social factors. Muscle weakness and the need
to be turned by a caregiver during the night have been
reported to be associated with sleep disturbance symptoms.20 Emotional and behavioural problems also contribute
to sleep disturbance symptoms. Parental exhaustion, sleep
deprivation, and poor mental health associated with caring
for a child with DMD, can contribute to vulnerability of
families and interfere with development of effective sleep
hygiene practices in affected males. Recommendations for
the assessment and management of sleep disturbances in
DMD should be interdisciplinary and extend beyond sleep
Fatigue in Duchenne Muscular Dystrophy Basmah El-Aloul et al.
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disordered breathing to include other sleep disorders, as well
as disease-related, psychological, and social factors.
Consistent with findings in other paediatric patient populations,24 our results demonstrated more depressive symptoms were associated with greater fatigue in males with
DMD from patients’ and parents’ perspectives. Males
with DMD are at increased risk of depression compared
with their typically developing peers or other paediatric
patient populations with physical disabilities.25 In a crosssectional study of adults with DMD, fatigue and affective
disorders coexisted in 24% of patients.26
Fatigue, sleep disturbance symptoms, and depressive
symptoms can occur independently, or coexist and exacerbate one another. Distinguishing fatigue from sleep disturbance symptoms and depressive symptoms, and
understanding causal relationships of this triad is essential
for developing targeted therapeutic strategies to achieve
satisfactory outcomes. Fatigue implies mental or physical
exhaustion, independent of exertion or amount of sleep,
whereas excessive daytime sleepiness implies a problem
with the sleep–wake cycle.6 Depression is characterized by
a general lack of interest in daily activities that are typically
enjoyed; however, this motivational component is unaffected in fatigue.27
Because we used a cross-sectional study design, multivariable regression analyses do not allow for conclusions
about directionality to be made, but serve to explore
adjusted associations between related factors and fatigue.
Fatigue, sleep disturbance symptoms, and depressive symptoms have complex bidirectional relationships. Despite a
strong association between depression and fatigue, causal
relationships between depression and fatigue remain to be
elucidated in longitudinal studies.28
Physical activity level was not associated with fatigue in
males with DMD, in contrast to previous findings whereby
physical inactivity was associated with fatigue in children
and adolescents with physical disabilities.29 It is possible
that the PAQ-C/A did not adequately capture variability in
physical activity level of males with DMD, reducing the
magnitude of association between physical activity level
and fatigue. Because most measures of physical activity
level are intended for use in typically developing children,
there is a need to develop feasible, valid, and reliable measures for use in patients with neuromuscular disorders,
which quantify lower and upper limb activity.
The following limitations of our study should be considered when interpreting the results. The cross-sectional
study design does not allow for temporality or causality of
associations to be established. Lack of statistical power
may have resulted in failure to detect associations between
clinical characteristics and fatigue. It is unclear whether
participants differ from non-participants with respect to
survey measures, or whether males enrolled in the CNDR
systematically differ from affected males not enrolled in
the CNDR with respect to clinical characteristics or care
practices. Nevertheless, the use of a national registry facilitated the inclusion of patients from multiple clinics and
250 Developmental Medicine & Child Neurology 2020, 62: 245–251

regions within Canada, enhancing generalizability. Because
questionnaires were not completed in a supervised setting,
we cannot be certain that patients and parents independently completed their respective questionnaires.
Our findings contribute to the limited literature on fatigue in paediatric neuromuscular disorders. We identified
fatigue to be a prominent issue in paediatric DMD,
emphasizing the need for healthcare providers to become
more familiar with fatigue in this population and to engage
in dialogue about fatigue with patients and caregivers. We
identified sleep disturbance symptoms and depressive
symptoms to be associated with fatigue in paediatric
DMD, contributing to our understanding of the subjective
experience of fatigue as a complex, multi-causal, and multidimensional phenomenon. Sleep disturbance symptoms
and depressive symptoms may be overlooked in routine
management of children and adolescents with DMD, warranting further investigation as potentially modifiable risk
factors for fatigue in this population. Child self-report and
parent proxy-report symptom-based measures are easy to
administer and are associated with a low participation burden. However, measures of sleep disturbance symptoms
and depressive symptoms provide limited information on
the associations of formal diagnoses of sleep disturbances
and depression with fatigue. To further understand these
relationships, polysomnographic data and psychiatric evaluations conducted by clinicians are required in future studies. Prospective cohort studies are required to establish
causality between patient characteristics and fatigue, to
facilitate the development of targeted therapeutic strategies
to reduce fatigue, and to improve health-related quality of
life. Qualitative studies can also provide insight into the
origin, severity, patterns, and impact of fatigue.
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SUPPORTING INFORMATION
The following additional material may be found online:
Figure S1: Relationship between physical activity level and
total fatigue by child self-report
Figure S2: Relationship between functional ability and total
fatigue by child self-report
Figure S3: Relationship between depressive symptoms and
total fatigue by child self-report
Figure S4: Relationship between sleep disturbance symptoms
and total fatigue by child self-report
Figure S5: Relationship between physical activity level and
total fatigue by parent proxy-report

Figure S6: Relationship between functional ability and total
fatigue by parent proxy-report
Figure S7: Relationship between depressive symptoms and
total fatigue by parent proxy-report
Figure S8: Relationship between sleep disturbance symptoms
and total fatigue by parent proxy-report

Table SI: Correlation analyses between sleep disturbance
symptoms and Pediatric Quality of Life Inventory Multidimensional Fatigue Scale scores by child self-report
Table SII: Correlation analyses between sleep disturbance
symptoms and Pediatric Quality of Life Inventory Multidimensional Fatigue Scale scores by parent proxy-report
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RESUMEN

FATIGA EN JOVENES
CON DISTROFIA MUSCULAR DE DUCHENNE
OBJETIVO Describir la fatiga en la distrofia muscular de Duchenne (DMD) desde la perspectiva de los pacientes y los padres, y
~ os y adolescentes con DMD.
explorar los factores de riesgo de fatiga en nin
M
ETODO Se utilizo un disen~ o transversal, con informacio n de diversos centros. En total 71 pacientes (todos varones; edad media
~ os, rango de edad 5 a 17 an
~ os) identificados a trave
s del Registro Canadiense de Enfermedades Neuromusculares, y sus
12 an
 utilizando la Escala de Fatiga Multidimensional del Inventario de
padres completaron cuestionarios. La fatiga subjetiva se evaluo
trica usando la informacio
 n provista por los nin
~ os y por los padres.
Calidad de Vida Pedia
RESULTADOS Los pacientes con DMD en todas las edades y etapas de la enfermedad experimentaron una mayor fatiga en
 n con los datos publicados en grupo de nin
~ os que que se desarrollan tıpicamente (controles). Los sıntomas de
comparacio
 n del suen
~ o se asociaron con mayor fatiga reportada por el nin
~ o (q = –0,42; p = 0,003) y por los padres (q = –0,51; p
alteracio
 n se asociaron con mayor fatiga reportada por el nin
~ o (q = –0,46; p <0,001) y por los padres (q =
<0,001). Los sıntomas de depresio
s baja se asocio
 con mayor fatiga reportada por los padres (q = 0,26; p = 0,03). El nivel
–0,45; p <0,001). La capacidad funcional ma
 n musculoesquele
 tica, respiratoria y cardıaca no se asociaron con la fatiga.
de actividad fısica y la funcio
 En la DMD pediatrica, los sıntomas de alteracio n del suen~ o y los sıntomas de depresio n son factores asociados
INTERPRETACION
 n adicional para facilitar el
con la fatiga. Estos factores son potencialmente modificables, lo que justifica una investigacio
 uticas para reducir la fatiga.
desarrollo de estrategias terape

RESUMO
FADIGA EM JOVENS COM DISTROFIA MUSCULAR DE DUCHENNE
OBJETIVO Descrever a fadiga na distrofia muscular de Duchenne (DMD) pela perspectiva de pacientes e pais, e explorar fatores de
risco para fadiga em criancßas e adolescentes com DMD.
M
ETODO Um desenho de estudo multice^ntrico e transversal foi usado. Setenta e um pacientes (todos do sexo masculino; idade
~o da idade 5–17a) identificados via Registro Canadense de Doencßas Neuromusculares, e seus pais,
mediana 12a, variacßa
rios. A fadiga subjetiva foi avaliada usando a Escada de Fadiga do Inventa
rio Pedia
trico de Qualidade
completaram os questiona
de Vida Multidimensional por auto-relato da criancßa e relato dos pais.
RESULTADOS Pacientes com DMD de varias idades e estagios da doencßa apresentaram mais fadiga comparados os controles com
 rbios do sono foram associados com maior fadiga pelo auto-relato
desenvolvimento tıpico de dados publicados. Sintomas de distu
das criancßas (q=–0,42; p=0,003) e pelo relato dos pais (q=–0,51; p<0,001). Sintomas depressivos foram associados com maior
fadiga no auto-relato das criancßas (q=–0,46; p<0,001) e pelo relato dos pais (q=–0,45; p<0,001). Menor capacidade funcional se
~o mu
 sculoassociou com maior fadiga de acordo com o relato dos pais (q=0,26; p=0,03). Nıvel de atividade fısica, e funcßa
 tica, respirato
 ria, e cardıaca na
~ o foram associadas com a fadiga.
esquele
~ Na DMD pediatrica, sintomas de distu rbios do sono e sintomas depressivos sa~o fatores potencialmente
INTERPRETAC
ß AO
 veis, que merecem investigacßa
~o adicional para facilitar o desenvolvimento de estrate
 gias terape
^ uticas para reduzir a
modifica
fadiga.

